每年專案
個人檔案
經歷
- 2020 臺北醫學大學醫務管理學系教授
- 2016 臺北醫學大學醫務管理學系副教授
指紋
查看啟用 Wei Pin Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis
Adikusuma, W., Chou, W-H., Lin, M-R., Ting, J., Irham, L. M., Perwitasari, D. A., Chang, W-P. & Chang, W-C., 2022, 於: Biomedicines. 10, 1研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information
Adikusuma, W., Irham, L. M., Chou, W. H., Wong, H. S. C., Mugiyanto, E., Ting, J., Perwitasari, D. A., Chang, W. P. & Chang, W. C., 十月 2021, 於: Frontiers in Immunology. 12, 724277.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Increased short- and long-term risk of sleep disorders in people with traumatic brain injury
Wang, Y. J., Chang, W. C., Wu, C. C., Chiang, Y. H., Chiu, W. T., Chen, K. Y. & Chang, W. P., 2021, 於: Neuropsychological Rehabilitation. 31, 2, p. 211-230 20 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
2 引文 斯高帕斯（Scopus） -
資料探勘應用於憂鬱症與自殺之因素分析與預測
沈曼瑄, 溫信財, 楊君萍, 廖若蘋 & 張偉斌, 2021, 於: 北市醫學雜誌. 18, 2, p. 174-194 21 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Prognostic effect of comorbid disease and immune gene expression on mortality in kidney cancer—a population based study
Wong, C. S., Chen, T. T., Chang, W. P., Wong, H. S. C., Wu, M. Y., Adikusuma, W., Lin, Y. F. & Chang, W. C., 六月 2020, 於: Cancers. 12, 6, p. 1-13 13 p., 1654.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus）
資料集
-
Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y. (Contributor), Li, W. (Contributor), Chang, Y. (Contributor), Peng, C. (Contributor), Cheng, C. (Contributor), Chang, W. P. (Contributor) & Chuang, C. (Contributor), Unknown Publisher, 一月 1 2016
DOI: 10.6084/m9.figshare.c.3642380.v1, https://figshare.com/collections/Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/3642380/1
資料集: Dataset
-
Additional file 1: of Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y. (Contributor), Li, W. (Contributor), Chang, Y. (Contributor), Peng, C. (Contributor), Cheng, C. (Contributor), Chang, W. P. (Contributor) & Chuang, C. (Contributor), Unknown Publisher, 一月 1 2016
DOI: 10.6084/m9.figshare.c.3642380_d1.v1, https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/4462352/1
資料集: Dataset